144 related articles for article (PubMed ID: 32920892)
21. Pathophysiological analysis of female Spontaneously Diabetic Torii fatty rats.
Ishii Y; Ohta T; Sasase T; Morinaga H; Ueda N; Hata T; Kakutani M; Miyajima K; Katsuda Y; Masuyama T; Shinohara M; Matsushita M
Exp Anim; 2010; 59(1):73-84. PubMed ID: 20224171
[TBL] [Abstract][Full Text] [Related]
22. Effects of food restriction on pancreatic islets in Spontaneously Diabetic Torii fatty rats.
Ishii Y; Ohta T; Sasase T; Morinag H; Miyajima K; Kakutani M
J Vet Med Sci; 2011 Feb; 73(2):169-75. PubMed ID: 20877155
[TBL] [Abstract][Full Text] [Related]
23. Chronological characterization of diabetes development in male Spontaneously Diabetic Torii rats.
Masuyama T; Komeda K; Hara A; Noda M; Shinohara M; Oikawa T; Kanazawa Y; Taniguchi K
Biochem Biophys Res Commun; 2004 Feb; 314(3):870-7. PubMed ID: 14741717
[TBL] [Abstract][Full Text] [Related]
24. FTY720, a sphingosine-1 phosphate receptor modulator, improves liver fibrosis in a mouse model by impairing the motility of bone marrow-derived mesenchymal stem cells.
Kong Y; Wang H; Wang S; Tang N
Inflammation; 2014 Aug; 37(4):1326-36. PubMed ID: 24682874
[TBL] [Abstract][Full Text] [Related]
25. Ascomycete derivative to MS therapeutic: S1P receptor modulator FTY720.
Hiestand PC; Rausch M; Meier DP; Foster CA
Prog Drug Res; 2008; 66():361, 363-81. PubMed ID: 18416311
[TBL] [Abstract][Full Text] [Related]
26. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.
Poti F; Costa S; Bergonzini V; Galletti M; Pignatti E; Weber C; Simoni M; Nofer JR
Vascul Pharmacol; 2012 Aug; 57(1):56-64. PubMed ID: 22459073
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of sphingosine-1-phosphate induced cardioprotection against I/R injury in diabetic rat heart: Possible involvement of glycogen synthase kinase 3β and mitochondrial permeability transition pore.
Rana A; Sharma S
Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):166-73. PubMed ID: 26582369
[TBL] [Abstract][Full Text] [Related]
28. Glucose intolerance and hyperlipidemia prior to diabetes onset in female Spontaneously Diabetic Torii (SDT) rats.
Shinohara M; Oikawa T; Sato K; Kanazawa Y
Exp Diabesity Res; 2004; 5(4):253-6. PubMed ID: 15763939
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine 1-phosphate receptor 1 as a useful target for treatment of multiple sclerosis.
Chiba K; Adachi K
Pharmaceuticals (Basel); 2012 May; 5(5):514-28. PubMed ID: 24281561
[TBL] [Abstract][Full Text] [Related]
30. Assessment of Pharmacological Responses to an Anti-diabetic Drug in a New Obese Type 2 Diabetic Rat Model.
Murai Y; Ohta T; Tadaki H; Miyajima K; Shinohara M; Fatchiyah F; Yamada T
Med Arch; 2017 Dec; 71(6):380-384. PubMed ID: 29416195
[TBL] [Abstract][Full Text] [Related]
31. FTY720 (Fingolimod), a modulator of sphingosine-1-phosphate receptors, increases baseline hypothalamic-pituitary adrenal axis activity and alters behaviors relevant to affect and anxiety.
Corbett B; Luz S; Sotuyo N; Pearson-Leary J; Moorthy GS; Zuppa AF; Bhatnagar S
Physiol Behav; 2021 Oct; 240():113556. PubMed ID: 34390688
[TBL] [Abstract][Full Text] [Related]
32. Depletion of T lymphocytes ameliorates cardiac fibrosis in streptozotocin-induced diabetic cardiomyopathy.
Abdullah CS; Li Z; Wang X; Jin ZQ
Int Immunopharmacol; 2016 Oct; 39():251-264. PubMed ID: 27494688
[TBL] [Abstract][Full Text] [Related]
33. Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K
Chang WT; Liu PY; Wu SN
Molecules; 2020 Oct; 25(19):. PubMed ID: 33023219
[TBL] [Abstract][Full Text] [Related]
34. The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice.
Yang Z; Chen M; Fialkow LB; Ellett JD; Wu R; Brinkmann V; Nadler JL; Lynch KR
Clin Immunol; 2003 Apr; 107(1):30-5. PubMed ID: 12738247
[TBL] [Abstract][Full Text] [Related]
35. The Sphingosine 1-Phosphate Analogue FTY720 Alleviates Seizure-induced Overexpression of P-Glycoprotein in Rat Hippocampus.
Gao F; Gao Y; Meng F; Yang C; Fu J; Li Y
Basic Clin Pharmacol Toxicol; 2018 Jul; 123(1):14-20. PubMed ID: 29380527
[TBL] [Abstract][Full Text] [Related]
36. Long-term effects of diabetes mellitus on voiding function in a new model of type 2 diabetes mellitus, the Spontaneously Diabetic Torii (SDT) rat.
Matsumoto Y; Torimoto K; Matsuyoshi H; Hirayama A; Fujimoto K; Yoshimura N; Hirao Y
Biomed Res; 2009 Dec; 30(6):331-5. PubMed ID: 20051641
[TBL] [Abstract][Full Text] [Related]
37. Diabetic peripheral neuropathy in Spontaneously Diabetic Torii-Lepr(fa) (SDT fatty) rats.
Yamaguchi T; Sasase T; Mera Y; Tomimoto D; Tadaki H; Kemmochi Y; Ohta T; Sato E; Matsushita M
J Vet Med Sci; 2012 Dec; 74(12):1669-73. PubMed ID: 22850562
[TBL] [Abstract][Full Text] [Related]
38. Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.
Kim S; Bielawski J; Yang H; Kong Y; Zhou B; Li J
Glia; 2018 Mar; 66(3):654-669. PubMed ID: 29193293
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of bone turnover, bone mass and bone strength in Spontaneously Diabetic Torii-Lepr fa rats.
Kimura S; Sasase T; Ohta T; Sato E; Matsushita M
J Bone Miner Metab; 2012 May; 30(3):312-20. PubMed ID: 22038286
[TBL] [Abstract][Full Text] [Related]
40. Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells.
Xie JH; Nomura N; Koprak SL; Quackenbush EJ; Forrest MJ; Rosen H
J Immunol; 2003 Apr; 170(7):3662-70. PubMed ID: 12646631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
